PATENT CLAIM ANALYSIS

Application Number: 15937053
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-11
Patent Classification: ["424", "400000"]

Abstract:
Corticosteroid microparticle formulations are provided for use for treating pain, including pain caused by inflammatory diseases such as osteoarthritis or rheumatoid arthritis, and for slowing, arresting or reversing structural damage to tissues caused by an inflammatory disease, for example damage to articular and/or peri-articular tissues caused by osteoarthritis or rheumatoid arthritis. Corticosteroid microparticle formulations are administered locally as a sustained release dosage form (with or without an immediate release component) that results in efficacy accompanied by clinically insignificant or no measurable effect on endogenous cortisol production.

Claim (Index 41):
The method of  claim 40 , herein the controlled or sustained release formulation is administered as one or more injections.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 90.0
- Lexical Diversity: 1.49206
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15459961', '14461884', '14461883', '13422994', '11607382']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8618819240630953
- 35 USC 102 Novelty (BERT): 0.6446021004971142
- Combined Prediction Score: 0.8401539417064972
- Mean Citation Score: 670.9881240000002
- Max Citation Score: 792.3644400000003
- Similarity Product: 565.1579365257599

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test